NCI Dictionary of Cancer Terms
The search textbox has an autosuggest feature. When you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. Use the arrow keys to move through the suggestions. To select a suggestion, hit the enter key. Using the escape key closes the listbox and puts you back at the textbox. The radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box.
liposome-encapsulated irinotecan hydrochloride PEP02 (LY-poh-some-en-KAP-soo-lay-ted I-rih-noh-TEE-kan HY-droh-KLOR-ide …)
|A form of the anticancer drug irinotecan hydrochloride that is contained inside very tiny, fat-like particles. It is being studied in the treatment of colorectal cancer that has spread to other parts of the body and in other types of cancer. Irinotecan hydrochloride blocks cell division and DNA repair, and it may kill cancer cells. Liposome-encapsulated irinotecan hydrochloride PEP02 may have fewer side effects and work better than irinotecan hydrochloride. It is a type of topoisomerase inhibitor and a type of camptothecin analog. Also called PEP02.|